PH-sensitive radiolabeled and superfluorinated ultra-small palladium nanosheet as a high-performance multimodal platform for tumor theranostics. (October 2018)

• Record Type: Journal Article
• Authors: Guo, Zhide; Chen, Mei; Peng, Chenyu; Mo, Shiguang; Shi, Changrong; Fu, Guifeng; Wen, Xuejun; Zhuang, Rongqiang; Su, Xinhui; Liu, Ting; Zheng, Nanfeng; Zhang, Xianzhong
• Is Part Of: Biomaterials. Volume 179(2018)
• Page Start: 134
• Page End: 143
• Publication Date: 2018-10
• Subjects: Palladium nanosheets -- Ultrasmall nanomaterials -- Radiolabeled nanoprobe -- SPECT imaging -- Tumor theranostics; Biomedical materials -- Periodicals; Biocompatible Materials -- Periodicals; Biomatériaux -- Périodiques; 610.28
• DOI: 10.1016/j.biomaterials.2018.06.040
• Languages: English
• ISSNs: 0142-9612

Abstract

Abstract: Radiolabeled nanomaterials, especially those with ultra-small structures, have been the research focus in recent years, and thus may open up new prospects for clinical diseases theranostics. Herein, fluorinated Pd nanosheets labeled with Gd or radionuclides are developed as multimodal platforms for tumor theranostics. These nanomaterials decorated by functional polyethylene glycol demonstrate ultrahigh 19 F MRI signal, ultrasmall size and good dispersibility. These ultrasmall materials exhibit good biocompatibility and easily to be modified for multimodal imaging (SPECT/MRI/PAI) by assembling the functional groups like building blocks. Furthermore, with high accumulation in tumor sites, under the guidance of multimodal imaging, combined photothermal therapy and radiotherapy are performed and synergistic effects are obtained. By comparing the in vivo behaviors of nanostructures labeled by different nuclides, the present study suggests the pH-sensitive radioiodinated Pd nanosheet which has unexpected T/NT ratio (>4-fold tumor-to-muscle ratio) in SPECT imaging and solves the critical high background issue of nanoprobes, could improve diagnostic accuracy and guide combination therapy. In summary, this functionalized nanoplatform with promising imaging and therapeutic efficacy has great potential for precision theranostic nanomedicines.